IFN Induces miR-21 through a Signal Transducer and Activator of Transcription 3–Dependent Pathway as a Suppressive Negative Feedback on IFN-Induced Apoptosis
Open accessPublished version of a preprint
Abstract
The microRNA miR-21 is overexpressed in many human cancers, wherein accumulating evidence indicates that it functions as an oncogene. Here, we report that the cytokine IFN rapidly induces miR-21 expression in human and mouse cells. Signal transducer and activator of transcription 3 (STAT3) was implicated in this pathway based on the lack of IFN effect on miR-21 expression in prostate cancer cells with a deletion in the STAT3 gene. STAT3 ablation abrogated IFN induction of miR-21, confirming the important role of STAT3 in regulating miR-21. Chromatin immunoprecipitation analysis showed that STAT3 directly bound the miR-21 promoter in response to IFN. Experiments in mouse embryo fibroblasts with a genetic deletion of the p65 NF-κB subunit showed that IFN-induced miR-21 expression was also dependent on NF-κB. STAT3 silencing blocked both IFN-induced p65 binding to the miR-21 promoter and p65 nuclear translocation. Thus, IFN-induced miR-21 expression is coregulated by STAT3 and NF-κB at the level of the miR-21 promoter. Several cell death regulators were identified as downstream targets of miR-21, including PTEN and Akt. Functional experiments in prostate cancer cells directly showed that miR-21 plays a critical role in suppressing IFN-induced apoptosis. Our results identify miR-21 as a novel IFN target gene that functions as a key feedback regulator of IFN-induced apoptosis.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Modulating miR-21 expression in in vivo and in vitro studies shows clear and important phenotype changes.
“Modulating its expression in in vivo and in vitro studies show clear and important phenotype changes.”
From miR-21: a non‐specific biomarker of all maladies (2021) · cites this paper as [16]
The Results section, “miR-21 expression suppresses IFN-induced apoptosis” (page unavailable), reports clear changes in apoptosis after miR-21 overexpression or knockdown in cultured cancer cells. Our copy does not report an in vivo experiment showing a phenotype change, so it supports only the in vitro part of the claim. (LLM, conf=0.87)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714 · see citing works
MicroRNA signatures in human cancers
Calin, G. A., & Croce, C. M. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1997 · Cited by 7,592 · see citing works
Darnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080 · see citing works
MicroRNA-21 Regulates Expression of the PTEN Tumor Suppressor Gene in Human Hepatocellular Cancer
Meng, F., Henson, R., Wehbe–Janek, H., Ghoshal, K., Jacob, S. T., & Patel, T. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.05.022 · Cited by 2,773 · see citing works
MicroRNA-21 Is an Antiapoptotic Factor in Human Glioblastoma Cells
Chan, J. A., Krichevsky, A. M., & Kosik, K. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0137 · Cited by 2,557 · see citing works
The STATs of cancer — new molecular targets come of age
Yu, H., & Jove, R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1275 · Cited by 2,278 · see citing works
Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery
Hennessy, B. T., Smith, D. L., Ram, P. T., Lu, Y., & Mills, G. B. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1902 · Cited by 2,183 · see citing works
Zhong, Z., Wen, Z., & Darnell, J. E. (1994) · Science · doi:10.1126/science.8140422 · Cited by 2,070 · see citing works
Meraz, M. A., White, J. M., Sheehan, K. C. F., Bach, E. A., Rodig, S. J., Dighe, A. S., Kaplan, D. H., Riley, J. K., Greenlund, A. C., Campbell, D., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81288-x · Cited by 1,656 · see citing works
Catlett-Falcone, R., Landowski, T. H., Oshiro, M. M., Turkson, J., Levitzki, A., Savino, R., Ciliberto, G., Moscinski, L., Fernández-Luna, J. L., Nuñez, G., et al. (1999) · Immunity · doi:10.1016/s1074-7613(00)80011-4 · Cited by 1,638 · see citing works
Si, M.-L., Zhu, S., Wu, H., Lu, Z., Wu, F., & Mo, Y.-Y. (2007) · Oncogene · doi:10.1038/sj.onc.1210083 · Cited by 1,600 · see citing works
Akira, S., Nishio, Y., Inoue, M., Wang, X.-J., We, S., Matsusaka, T., Yoshida, K., Sudo, T., Naruto, M., & Kishimoto, T. (1994) · Cell · doi:10.1016/0092-8674(94)90235-6 · Cited by 1,019 · see citing works
Sheedy, F. J., Palsson-McDermott, E., Hennessy, E. J., Martin, C., O'Leary, J. J., Ruan, Q., Johnson, D. S., Chen, Y., & O'Neill, L. A. J. (2010) · Nature Immunology · doi:10.1038/ni.1828 · Cited by 1,005 · see citing works
Interferon modulation of cellular microRNAs as an antiviral mechanism
Pedersen, I. M., Cheng, G., Wieland, S. F., Volinia, S., Croce, C. M., Chisari, F. V., & David, M. (2007) · Nature · doi:10.1038/nature06205 · Cited by 850 · see citing works
MicroRNAs: Novel Regulators Involved in the Pathogenesis of Psoriasis?
Sonkoly, E., Wei, T., Janson, P. C. J., Sääf, A., Lundeberg, L., Tengvall-Linder, M., Norstedt, G., Alenius, H., Homey, B., Scheynius, A., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000610 · Cited by 754 · see citing works
Löffler, D., Brocke-Heidrich, K., Pfeifer, G., Stocsits, C., Hackermüller, J., Kretzschmar, A. K., Burger, R., Gramatzki, M., Blumert, C., Bauer, K., et al. (2007) · Blood · doi:10.1182/blood-2007-03-081133 · Cited by 637 · see citing works
Wu, F., Zikusoka, M. N., Trindade, A. J., Dassopoulos, T., Harris, M. L., Bayless, T. M., Brant, S. R., Chakravarti, S., & Kwon, J. H. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.07.068 · Cited by 509 · see citing works
Iliopoulos, D., Malizos, K., Oikonomou, P., & Tsezou, A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003740 · Cited by 501 · see citing works
MicroRNAs Are Aberrantly Expressed in Hypertrophic Heart
Cheng, Y., Ji, R., Yue, J., Yang, J., Liu, X., Chen, H., Dean, D. B., & Zhang, C. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.061170 · Cited by 491 · see citing works
Self-citationFrequent inactivation of PTEN in prostate cancer cell lines and xenografts.
Vlietstra, R. J., van Alewijk, D. C., Hermans, K., van Steenbrugge, G. J., & Trapman, J. (1998) · PubMed · Cited by 381 · see citing works
Zhou, X., Ren, Y., Moore, L. M., Mei, M., You, Y., Xu, P., Wang, B., Wang, G., Jia, Z., Pu, P., et al. (2010) · Laboratory Investigation · doi:10.1038/labinvest.2009.126 · Cited by 358 · see citing works
Role of STAT3 in Type I Interferon Responses
Ho, H. H., & Ivashkiv, L. B. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511797200 · Cited by 302 · see citing works
Pfeffer, L. M., Mullersman, J. E., Pfeffer, S. R., Murti, A., Shi, W., & Yang, C. H. (1997) · Science · doi:10.1126/science.276.5317.1418 · Cited by 258 · see citing works
Self-citationmiR-21: an oncomir on strike in prostate cancer
Folini, M., Gandellini, P., Longoni, N., Profumo, V., Callari, M., Pennati, M., Colecchia, M., Supino, R., Veneroni, S., Salvioni, R., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-12 · Cited by 229 · see citing works
Yang, C. H., Murti, A., Pfeffer, S. R., Kim, J. G., Donner, D. B., & Pfeffer, L. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011006200 · Cited by 200 · see citing works
Self-citationYang, C., Murti, A., & Pfeffer, L. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.10.5568 · Cited by 128 · see citing works
Self-citationClark, J., Edwards, S. E., Feber, A., Flohr, P., John, M. M., Giddings, I., Crossland, S., Stratton, M. R., Wooster, R., Campbell, C., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206247 · Cited by 100 · see citing works
Pfeffer, L. M., Kim, J.-G., Pfeffer, S. R., Carrigan, D. J., Baker, D. P., Wei, L., & Homayouni, R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308975200 · Cited by 72 · see citing works
Self-citationOhno, M., Natsume, A., Kondo, Y., Iwamizu, H., Motomura, K., Toda, H., Ito, M., Kato, T., & Wakabayashi, T. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0319 · Cited by 54 · see citing works
Identification of CXCL11 as a STAT3-Dependent Gene Induced by IFN
Yang, C. H., Wei, L., Pfeffer, S. R., Du, Z., Murti, A., Valentine, W. J., Zheng, Y., & Pfeffer, L. M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.2.986 · Cited by 46 · see citing works
Self-citationThe role of constitutively activated STAT3 in B16 melanoma cells
Pfeffer, L. M., Yang, C. H., Fan, M., & Yue, J. (2010) · International Journal of Interferon Cytokine and Mediator Research · doi:10.2147/ijicmr.s6657 · Cited by 30 · see citing works
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- [5]Yang CH Shi W Basu L Direct association of STAT3 with the IFNAR1 signal transducing chain of the type I IFN receptor J Biol Chem 1996 271 8057 61 8626489
Cited by
Sorted by citations
Interferon-stimulated genes: A complex web of host defenses
Schneider, W. M., Chevillotte, M. D., & Rice, C. M. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120231 · Cited by 3,067 · see citing works
miR-21: a non‐specific biomarker of all maladies
Jenike, A. E., & Halushka, M. K. (2021) · Biomarker Research · doi:10.1186/s40364-021-00272-1 · Cited by 248 · see citing works
MicroRNA-21's role in PTEN suppression and PI3K/AKT activation: Implications for cancer biology
Chawra, H. S., Agarwal, M., Mishra, A., Chandel, S. S., Singh, R. P., Dubey, G., Kukreti, N., & Singh, M. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155091 · Cited by 91 · see citing works
- Authors
- Yang, C. H., Yue, J., Fan, M., & Pfeffer, L. M.
- Affiliations
- University of Tennessee Health Science Center (US)
- Corresponding author
- Pfeffer, Lawrence M.
- Venue
- Cancer Research
- Published
- 2010-10-13
- Volume
- 70
- Issue
- 20
- Pages
- 8108-8116
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- PMC
- PMC3014825
- OpenAlex
- W2072751712
- Cited by
- 179
- References
- 31
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 8 · 2023: 9 · 2022: 4 · 2021: 8 · 2020: 9 · 2019: 7 · 2018: 9 · 2017: 11 · 2016: 17 · 2015: 24 · 2014: 16 · 2013: 15 · 2012: 20
- FWCI
- 5.04
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Biogen
- IC Design Education Center
- U.S. Public Health Service (RHL095957)
- National Heart, Lung, and Blood Institute (R21HL095957)
- National Cancer Institute (R01CA133322, CA133322, R01CA140346)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Health Sciences › Medicine › Oncology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Keywords
- miR-21, interferon, STAT3, NF-κB, NF-κB p65, negative feedback regulation, apoptosis, PTEN, Akt, prostate cancer, microRNA regulation, oncogenes
- MeSH terms
- Animals, Feedback, Fibroblasts, Humans, Interferons, Male, Prostatic Neoplasms, Signal Transduction, Apoptosis, DNA Primers, DNA, Complementary, Mice, Knockout, Gene Silencing, MicroRNAs, STAT3 Transcription Factor, Mice, Transcription Factor RelA
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review